Awarded

AFLIBERCEPT [40 MG/ ML; SOL INJ; FRS/ SERINGA]- FRASCO

Name: AFLIBERCEPT [40 MG/ ML; SOL INJ; FRS/ SERINGA]- FRASCO
Creator: OUTRAS INSTITUIÇÕES DE SAÚDE
Published: 2026-09-21
License: https://ted.europa.eu/en/simap/legal-notice

Original language: Portuguese

Track this recordWith Adjudera Pro, get alerted before a contract here runs out.

Buyer: OUTRAS INSTITUIÇÕES DE SAÚDE
Winners: ADVANZ PHARMA PORTUGAL, UNIPESSOAL LDA
Contract value: €321,686
Bids received: 1
Published: 21 Sept 2026
Awarded: 3 Sept 2026
Contract start: 3 Sept 2026
Contract end: 20 Sept 2027estimated
Sector: Medical equipment and pharmaceuticals
Region: Extra-Regio NUTS 3
Source: Original notice on TED (655857-2026)

More awards from this buyer

Awarded	Buyer	Winner	Contract value	Published
NINTEDANIB [100MG; CÁPS] + NINTEDANIB [150MG; CÁPS]	OUTRAS INSTITUIÇÕES DE SAÚDE	ACCORD HEALTHCARE, UNIPESSOAL, LDA	€8,934	21 Sept 2026
NINTEDANIB [100MG; CÁPS] + NINTEDANIB [150MG; CÁPS]	OUTRAS INSTITUIÇÕES DE SAÚDE	GENERIS - FARMACÊUTICA, S.A.	€26,813	21 Sept 2026
NINTEDANIB [100MG; CÁPS] + NINTEDANIB [150MG; CÁPS]	OUTRAS INSTITUIÇÕES DE SAÚDE	GENERIS - FARMACÊUTICA, S.A.	€44,928	21 Sept 2026
NINTEDANIB [150MG; CÁPS]	OUTRAS INSTITUIÇÕES DE SAÚDE	ACCORD HEALTHCARE, UNIPESSOAL, LDA	€7,134	21 Sept 2026
NINTEDANIB [150MG; CÁPS]	OUTRAS INSTITUIÇÕES DE SAÚDE	GENERIS - FARMACÊUTICA, S.A.	€246,125	21 Sept 2026
NINTEDANIB [100MG; CÁPS]	OUTRAS INSTITUIÇÕES DE SAÚDE	Teva Pharma – Produtos Farmacêuticos, Lda	€35,448	21 Sept 2026